{"disease":{"id":"control-arm-in-risankizumab-phase-3-trials-likely-psoriasis-crohn-s-disease-or-ulcerative-colitis-based-on-risankizumab-s-development-program","name":"control arm in risankizumab phase 3 trials likely psoriasis crohn s disease or ulcerative colitis based on risankizumab s development program"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}